Premature mortality: A neglected outcome in rheumatic diseases?

Arthritis Care and Research

Volumn 67, Issue 8, 2015, Pages 1043-1046

  Pincus, Theodore ^a   Gibson, Kathryn A ^b   Block, Joel A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ABNORMAL LABORATORY RESULT; ANKYLOSING SPONDYLITIS; CAUSE OF DEATH; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; GOUT; HUMAN; OSTEOARTHRITIS; POLYMYOSITIS; PREMATURE MORTALITY; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS; MORTALITY;

HUMANS; MORTALITY, PREMATURE; RHEUMATIC DISEASES;

EID: 84937878909     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22554     Document Type: Editorial

References (34)

1. Pincus T, Sokka T., Mortality in rheumatic diseases. Clin Exp Rheumatol 2008; Suppl 51: S1-4.
2. Hochberg MC., Mortality in osteoarthritis. Clin Exp Rheumatol 2008; Suppl 51: S120-4.
3. Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011; 342: d1165.
4. Choi HK, Curhan G., Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900.
5. Kim SY, De, Vera MA, Choi HK., Gout and mortality. Clin Exp Rheumatol 2008; Suppl 51: S115-9.
6. Pincus T, Callahan LF., Taking mortality in rheumatoid arthritis seriously: predictive markers, socioeconomic status and comorbidity. J Rheumatol 1986; 13: 841-5.
7. Gonzalez A, Kremers HM, Crowson CS, Nicola PJ, Davis JM III, Therneau TM, et al., The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-7.
8. Meune C, Touze E, Trinquart L, Allanore Y., Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009; 48: 1309-13.
9. Radovits BJ, Fransen J, Al Shamma S, Eijsbouts AM, van Riel PL, Laan RF., Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010; 62: 362-70.
10. Dadoun S, Zeboulon-Ktorza N, Combescure C, Elhai M, Rozenberg S, Gossec L, et al., Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 2013; 80: 29-33.
11. Widdifield J, Bernatsky S, Paterson JM, Tomlinson G, Tu K, Kunya B, et al., Trends in excess mortality among patients with rheumatoid arthritis in Ontario, Canada. Arthritis Care Res (Hoboken) 2015; 67: 1047-53.
12. Humphreys JH, Warner A, Chipping J, Marshall T, Lunt M, Symmons DP, et al., Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2014; 66: 1296-301.
13. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al., Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-7.
14. Wong K, Gladman DD, Husted J, Long JA, Farewell VT., Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-72.
15. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM., Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000; 29: 296-304.
16. Lehtinen K., Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993; 52: 174-6.
17. Karassa FB, Ioannidis JP., Mortality in systemic sclerosis. Clin Rheumatol 2008; Suppl 51: S85-93.
18. Airio A, Kautiainen H, Hakala M., Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Exp Rheumatol 2006; 25: 234-9.
19. Lane SE, Watts RA, Shepstone L, Scott DG., Primary systemic vasculitis: clinical features and mortality. QJM 2005; 98: 97-111.
20. Nakhaee F, Black D, Wand H, McDonald A, Law M., Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003. Sexual Health 2009; 6: 129-34.
21. Florkowski CM, Scott RS, Moir CL, Graham PJ., Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand. Diabet Med 1998; 15: 386-92.
22. Krause D, Schleusser B, Herborn G, Rau R., Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000; 43: 14-21.
23. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F., Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-7.
24. Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, et al., Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 670-5.
25. Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, et al., All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 2007; 66: 880-5.
26. Van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW., Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology (Oxford) 2010; 49: 2210-6.
27. Callahan LF, Pincus T., Mortality in the rheumatic diseases. Arthritis Care Res 1995; 8: 229-41.
28. Boers M, Dijkmans B, Gabriel S, Maradit-Kremers H, O'Dell J, Pincus T., Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum 2004; 50: 1734-9.
29. Van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, et al., Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009; 68: 1395-400.
30. Pelletier J, Martel-Pelletier J, Abramson SB., Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 1237-47.
31. Pincus T, Sokka T., Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am 2009; 35: 731-4.
32. Steen VD, Medsger TA Jr., The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40: 1984-91.
33. Pincus T., Why should rheumatologists collect patient self-report questionnaires in routine rheumatologic care? Rheum Dis Clin North Am 1995; 21: 271-319.
34. Crimmins E, Saito Y., Change in the prevalence of diseases among older Americans: 1984-1994. 2000. URL: http://www.demographic-research.org/volumes/vol3/9/3-9.pdf.